Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting
- PMID: 10844002
- DOI: 10.1074/jbc.M910350199
Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting
Abstract
Fasting causes lipolysis in adipose tissue leading to the release of large quantities of free fatty acids into circulation that reach the liver where they are metabolized to generate ketone bodies to serve as fuels for other tissues. Since fatty acid-metabolizing enzymes in the liver are transcriptionally regulated by peroxisome proliferator-activated receptor alpha (PPARalpha), we investigated the role of PPARalpha in the induction of these enzymes in response to fasting and their relationship to the development of hepatic steatosis in mice deficient in PPARalpha (PPARalpha(-/-)), peroxisomal fatty acyl-CoA oxidase (AOX(-/-)), and in both PPARalpha and AOX (double knock-out (DKO)). Fasting for 48-72 h caused profound impairment of fatty acid oxidation in both PPARalpha(-/-) and DKO mice, and DKO mice revealed a greater degree of hepatic steatosis when compared with PPARalpha(-/-) mice. The absence of PPARalpha in both PPARalpha(-/-) and DKO mice impairs the induction of mitochondrial beta-oxidation in liver following fasting which contributes to hypoketonemia and hepatic steatosis. Pronounced steatosis in DKO mouse livers is due to the added deficiency of peroxisomal beta-oxidation system in these animals due to the absence of AOX. In mice deficient in AOX alone, the sustained hyperactivation of PPARalpha and up-regulation of mitochondrial beta-oxidation and microsomal omega-oxidation systems as well as the regenerative nature of a majority of hepatocytes containing numerous spontaneously proliferated peroxisomes, which appear refractory to store triglycerides, blunt the steatotic response to fasting. Starvation for 72 h caused a decrease in PPARalpha hepatic mRNA levels in wild type mice, with no perceptible compensatory increases in PPARgamma and PPARdelta mRNA levels. PPARgamma and PPARdelta hepatic mRNA levels were lower in fed PPARalpha(-/-) and DKO mice when compared with wild type mice, and fasting caused a slight increase only in PPARgamma levels and a decrease in PPARdelta levels. Fasting did not change the PPAR isoform levels in AOX(-/-) mouse liver. These observations point to the critical importance of PPARalpha in the transcriptional regulatory responses to fasting and in determining the severity of hepatic steatosis.
Similar articles
-
Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.J Biol Chem. 1999 Jul 2;274(27):19228-36. doi: 10.1074/jbc.274.27.19228. J Biol Chem. 1999. PMID: 10383430
-
Peroxisomal beta-oxidation and steatohepatitis.Semin Liver Dis. 2001;21(1):43-55. doi: 10.1055/s-2001-12928. Semin Liver Dis. 2001. PMID: 11296696 Review.
-
Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism.J Biol Chem. 1999 May 28;274(22):15775-80. doi: 10.1074/jbc.274.22.15775. J Biol Chem. 1999. PMID: 10336479
-
Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.J Clin Invest. 1999 Jun;103(11):1489-98. doi: 10.1172/JCI6223. J Clin Invest. 1999. PMID: 10359558 Free PMC article.
-
Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis.Curr Mol Med. 2003 Sep;3(6):561-72. doi: 10.2174/1566524033479537. Curr Mol Med. 2003. PMID: 14527087 Review.
Cited by
-
β2-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states.Am J Physiol Endocrinol Metab. 2021 Jul 1;321(1):E90-E104. doi: 10.1152/ajpendo.00651.2020. Epub 2021 May 24. Am J Physiol Endocrinol Metab. 2021. PMID: 34029162 Free PMC article.
-
Circadian clock controls rhythms in ketogenesis by interfering with PPARα transcriptional network.Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2205755119. doi: 10.1073/pnas.2205755119. Epub 2022 Sep 26. Proc Natl Acad Sci U S A. 2022. PMID: 36161962 Free PMC article.
-
A Network Pharmacology Study on the Active Components and Targets of the Radix Ginseng and Radix Bupleuri Herb Pair for Treating Nonalcoholic Fatty Liver Disease.Evid Based Complement Alternat Med. 2022 Feb 8;2022:1638740. doi: 10.1155/2022/1638740. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35178098 Free PMC article.
-
Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.Gene Expr. 2001;9(6):291-304. doi: 10.3727/000000001783992533. Gene Expr. 2001. PMID: 11764000 Free PMC article.
-
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease.Mol Metab. 2019 Nov;29:99-113. doi: 10.1016/j.molmet.2019.08.019. Epub 2019 Aug 28. Mol Metab. 2019. PMID: 31668396 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases